Knowledge Management System of Kunming Institute of Botany,CAS
Cyclopeptide RA-V Inhibits Organ Enlargement and Tumorigenesis Induced by YAP Activation | |
Ji, Xinyan1,2; Song, Lihua3,4; Sheng, Li5; Gao, Anhui5; Zhao, Yang1,2; Han, Shixun1,2; Zhang, Yuchao1,2; Zhu, Chu1,2; Zhao, Simeng6; Wang, Zhe3,4![]() | |
2018-11-01 | |
发表期刊 | CANCERS
![]() |
ISSN | 2072-6694 |
卷号 | 10期号:11页码:18 |
摘要 | The Hippo pathway restricts organ size during development and its inactivation plays a crucial role in cancer. Yes-associated protein (YAP) and its paralog transcriptional coactivator with PSD-95/Dlg/ZO-1 (PDZ)-binding motif (TAZ) are transcription co-activators and effectors of the Hippo pathway mediating aberrant enlargement of organs and tumor growth upon Hippo pathway inactivation. It has been demonstrated that genetic inactivation of YAP could be an effective approach to inhibit tumorigenesis. In order to identify pharmacological inhibitors of YAP, we screened a library of 52,683 compounds using a YAP-specific reporter assay. In this screen we identified cyclopeptide RA-V (deoxybouvardin) as a specific inhibitor of YAP and TAZ but not other reporters. Unexpectedly, later experiments demonstrated that RA-V represses the protein but not mRNA levels of YAP target genes. Nevertheless, RA-V strongly blocks liver enlargement induced by Mst1/2 knockout. Furthermore, RA-V not only inhibits liver tumorigenesis induced by YAP activation, but also induces regression of established tumors. We found that RA-V inhibits dedifferentiation and proliferation, while inducing apoptosis of hepatocytes. Furthermore, RA-V also induces apoptosis and inhibits proliferation of macrophages in the microenvironment, which are essential for YAP-induced tumorigenesis. RA-V is thus a drug candidate for cancers involving YAP/TAZ activation. |
关键词 | hippo pathway YAP TAZ RA-V cancer organ size protein synthesis |
收录类别 | SCI |
语种 | 英语 |
WOS记录号 | WOS:000451307700056 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/63290 |
专题 | 中国科学院昆明植物研究所 |
通讯作者 | Li, Jia; Tan, Ninghua; Zhao, Bin |
作者单位 | 1.Zhejiang Univ, Life Sci Inst, MOE Key Lab Biosyst Homeostasis & Protect, Hangzhou 310058, Zhejiang, Peoples R China 2.Zhejiang Univ, Life Sci Inst, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China 3.China Pharmaceut Univ, Sch Tradit Chinese Pharm, Nanjing 211198, Jiangsu, Peoples R China 4.China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 211198, Jiangsu, Peoples R China 5.Natl Ctr Drug Screening, 189 Guoshoujing Rd, Shanghai 201203, Peoples R China 6.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming 650201, Yunnan, Peoples R China 7.Hangzhou Normal Univ, Inst Aging Res, Hangzhou 311121, Zhejiang, Peoples R China 8.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China |
推荐引用方式 GB/T 7714 | Ji, Xinyan,Song, Lihua,Sheng, Li,et al. Cyclopeptide RA-V Inhibits Organ Enlargement and Tumorigenesis Induced by YAP Activation[J]. CANCERS,2018,10(11):18. |
APA | Ji, Xinyan.,Song, Lihua.,Sheng, Li.,Gao, Anhui.,Zhao, Yang.,...&Zhao, Bin.(2018).Cyclopeptide RA-V Inhibits Organ Enlargement and Tumorigenesis Induced by YAP Activation.CANCERS,10(11),18. |
MLA | Ji, Xinyan,et al."Cyclopeptide RA-V Inhibits Organ Enlargement and Tumorigenesis Induced by YAP Activation".CANCERS 10.11(2018):18. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论